STAAR SURGICAL CO — Director's Dealing 2025

Mar 12, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2025-03-07

Reporting Person: Williams Patrick F. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-07	Common Stock	M	2614	—	Acquired	40953	Direct
2025-03-07	Common Stock	M	3075	—	Acquired	44028	Direct
2025-03-10	Common Stock	M	4061	—	Acquired	48089	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-07	Performance Stock Units	$0	M	2614	Disposed		Common Stock (2614)	Direct
2025-03-07	Restricted Stock Units	$0	M	3075	Disposed		Common Stock (3075)	Direct
2025-03-10	Restricted Stock Units	$0	M	4061	Disposed		Common Stock (4061)	Direct

Footnotes

F1: Reflects performance stock units (PSUs) granted to the Reporting Person on March 7, 2022, based on the Corporation's performance relative to pre-established financial metrics. These PSUs vested as to 1/3 (2,614 shares) on March 7, 2023, 1/3 (2,614 shares) on March 7, 2024, and 1/3 (2,614 shares) on March 7, 2025.

F2: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 7, 2022. These RSUs vested as to 1/3 (3,075 shares) on March 7, 2023, 1/3 (3,075 shares) on March 7, 2024, and 1/3 (3,075 shares) on March 7, 2025.

F3: Reflects RSUs granted to the Reporting Person on March 10, 2023. These RSUs vested as to 1/3 (4,061 shares) on March 10, 2024, 1/3 (4,061 shares) on March 10, 2025, and will vest as to the remaining 1/3 (4,062 shares) on March 10, 2026.

F4: Includes previously granted RSUs, which are subject to future vesting.

F5: Each PSU and RSU represents the right to receive one share of the Corporation's common stock upon vesting.